Stockreport

Traws Pharma Reports Positive Interim Clinical Data with Ratutrelvir Versus PAXLOVID™, Shows Activity in PAXLOVID-Ineligible COVID-19 Patients [Yahoo! Finance]

Traws Pharma, Inc.  (TRAW) 
PDF Activity shown in Paxlovid ® -ineligible patients, representing a significant population with few effective treatment options Final data analysis to be reported in Ja [Read more]